Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will… Read More
Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions.… Read More
Silverback Therapeutics, a stealthy biotechnology startup, gave the first glimpse of its technology Wednesday as it announced an additional $37.5… Read More
Despite some knock-out successes and world-class research, Seattle’s biotechnology industry has remained relatively small compared to other hubs around the… Read More
Silverback Therapeutics, a stealthy biotech startup co-founded by investor, entrepreneur and University of Washington neurosurgery professor Peter Thompson, has raised $10… Read More
